Why cannabis works for some patients in specific situations, not others

This paper challenges how we evaluate medicinal cannabis in palliative care by questioning the traditional scientific approach of averaging patient responses across populations. The research introduces a contextual effectiveness framework that recognizes an important truth: patients may genuinely benefit from cannabis in some situations but not others, and this variation isn't simply placebo or measurement error. Rather than seeing patients as binary "responders" or "non-responders," the authors argue that the same patient can experience real, meaningful improvement in quality of life within specific contexts—such as particular times of day, social settings, or disease stages—while showing no benefit in averaged clinical trials.

The key limitation the paper identifies is that standard randomized controlled trials (RCTs) measure average effects across diverse patients, which can mask the genuine contextual benefits some individuals experience. For discrete symptoms like pain intensity, averaging makes sense because pain reduction is measurable and consistent. However, subjective outcomes like overall well-being, mood, and quality of life vary dramatically depending on life circumstances, disease progression, and personal contexts. The authors argue this doesn't invalidate patients' experiences—it simply means we need better tools to measure and understand them scientifically.

To bridge the gap between positive patient reports and negative trial outcomes, the paper proposes a dual-pathway evidence model: first, traditional RCTs to establish population-level efficacy, followed by post-trial contextual surveillance studies (CSS) that track how individual patients respond across different life situations and time periods. This approach maintains scientific rigor while enabling truly person-centered care where clinicians and patients can identify when, how, and for whom cannabis works—creating more realistic expectations and better treatment decisions in palliative settings.